GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

UK health & beauty specialists lose out to discounters in value for money rankings, finds GlobalData

UK health & beauty specialists are struggling to compete with low-priced discounters, as consumers are not recognizing the additional value for money that comes from their better ranges, product quality, and service. With personal finances still recovering from the impact of inflationary pressure, consumers still prefer to shop at discounters for essentials, according to GlobalData, […]
Read more

CNS innovator oligonucleotide licensing value surges by 339% to $2.8 billion in 2024, reveals GlobalData

Innovator oligonucleotide-based drugs targeting central nervous system (CNS) disorders have seen a remarkable 339% increase in licensing agreement deal value, rising from $640 million in 2023 to $2.81 billion in 2024, according to GlobalData, a leading data and analytics company. Oligonucleotides, which are short synthetic DNA or RNA strands, are utilized in precision medicine to […]
Read more

GeneCentric’s funding highlights growing investor interest in RNA-driven diagnostics in precision oncology, says GlobalData

GeneCentric Therapeutics has recently secured $8 million in new funding to advance its RNA-based liquid biopsy platform. The financing will support the development and commercialization of GeneCentric’s platform, which enables non-invasive tumor profiling to guide treatment decisions and monitor disease progression. The funding reflects the growing investor enthusiasm for RNA-driven diagnostics in precision oncology, according […]
Read more

Diagnosed prevalent cases of pulmonary arterial hypertension to decline by 0.08% AGR in 7MM during 2024-34, forecasts GlobalData

The diagnosed prevalent cases of pulmonary arterial hypertension (PAH) in the seven major markets (*7MM) are projected to decrease from 76,645 in 2024 to 76,035 in 2034 at an annual growth rate (AGR) of negative 0.08%, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “Pulmonary Arterial Hypertension (PAH) – Epidemiology Analysis and […]
Read more
1 … 70 71 72 73 74 … 784